Sponsors

PlatinumReception SponsorEvent SponsorRegistration & LanyardPlatinum Event PartnerEvent Partners

Life Sciences Conferences

The Burrill Personalized Medicine Meeting

Agenda

Day One - October 3, 2011

7:30 – 8:30 a.m.
Breakfast & Registration

8:30 – 9:30 a.m.
Welcome and Personalized Medicine Industry Update
An overview of the current state of the personalized medicine industry in the context of a turbulent, challenging economy, and in the “post healthcare reform environment”
G. Steven Burrill, CEO, Burrill & Company

9:30 – 9:45 a.m.
Break

9:45 – 10:30 a.m.
We are well beyond the concept of the 3 Ps (Personalized, Predictive, & Preemptive medicine) -- Where are we really with:

“The Science” - Keynote Presentation
Ralph Snyderman, M.D., Chancellor Emeritus, Duke University

10:30 a.m. – 11:45 p.m.
Panel: “The Business”
Panelists:
Pierre Cassigneul, President and Chief Executive Officer, XDx
Deb Kilpatrick, SVP of Commercial Operations, CardioDx
Matthew McManus, MD, PhD, President & CEO, PrimeraDx
Mickey Urdea, PhD, Co-founder, Chairman and CSO, Tethys Bioscience
Moderator: Ralph Snyderman, M.D., Chancellor Emeritus, Duke University 

11:45 – 1:00 p.m.
‘Conversations with Experts’ Luncheon

1:00 – 2:00 p.m.
Keynote Presentation: “It from Bits”: Managing massive data as a critical challenge for biomedical R&D and healthcare delivery.
Dr. George Poste, DVM, PhD, Chief Scientist, Complex Adaptive Systems Initiative; Regents' Professor and Del E. Webb Chair in Health Innovation, Arizona State University
Introduced by: G. Steven Burrill, CEO, Burrill & Company 

2:00 – 3:00 p.m.
Panel: Is Personalized Medicine just the next generation of MDx? Where is the real action?
Panelists:
Stephen Little, Vice President Personalized Healthcare, Qiagen
Matthew Rosamond, Director - Personalized Medicine Practice, PwC
Brad Stewart, Chairman, CEO and President, Cylex
Moderator: Bryant Fong, Managing Director, Burrill & Company

3:00 – 3:15 p.m.
Break

3:15 – 3:45 p.m.
Company Presentation:
Aris Persidis, PhD, President, Co-Founder, Biovista
Dave Albert, MD, Founder, AliveCor
Introduced by: G. Steven Burrill, CEO, Burrill & Company

3:45 – 4:45 p.m.
Panel: Let’s look at Cancer – What’s happening in PM?
Panelists:
Michael Cantor, Director, Healthcare Informatics, Pfizer, Inc.
Carlos Santos, Chief Scientific Officer, Biovest International, Inc.
Moderator: Jay M. Tenenbaum, Ph.D. Chairman, CEO, and Chief Scientist, CollabRx

4:45 – 5:45 p.m.
Keynote Presentation: Ion Torrent Powered Genetic Medicine
Gregory Lucier, Chairman & CEO, Life Technologies
Introduced by: G. Steven Burrill, CEO, Burrill & Company

5:45 p.m.
Meeting Wrap-Up (Day One)
G. Steven Burrill, CEO, Burrill & Company

5:45 – 7:30 p.m.
Networking Reception
Sponsored By: Fenwick & West LLP

Day 2 - October 4, 2011

7:30 – 8:15 a.m.
Breakfast

8:15 – 9:15 a.m.
Keynote Presentation: The $1,000 Genome: The Revolution in DNA Sequencing and the New Era of Personalized Medicine
Kevin Davies, Science Writer, Editor-in-Chief of "Bio-IT World" and Author of "The $1000 Genome Introduced by: G. Steven Burrill, CEO, Burrill & Company

9:15 – 10:15 a.m.
Panel: The Revolutionary War: The Battle to Dominate Next-Gen Sequencing
Players:
Clifford Reid, CEO, Complete Genomics
Jay Flatley, CEO, Illumina, Inc.
Hugh Martin, CEO, Pacific Biosciences
Paul Billings, Chief Medical Officer, Life Technologies
Moderator: G. Steven Burrill, CEO, Burrill & Company

10:15 – 10:30 a.m.
Break

10:30– 10:45 a.m.
Presentation: The Role of Companion Diagnostics in Moving Pharmacogenomics Forward
Joshua Cohen, Research Associate Professor of Medicine, Tufts University

10:45– 11:45 a.m.
Keynote Presentation: Reengineering the Therapeutic Development Pipeline
Francis Collins, MD, PhD, Director, NIH
Introduced by: G. Steven Burrill, CEO, Burrill & Company

11:45 a.m. – 12:45 p.m.
Panel: Consumer Protection or Government Intrusion: Is Regulation appropriate? Is it different in Europe? Japan? Are companies moving away from “betting the company” on the FDA?
Panelists:
Dietrich Stephan, President and CEO, Ignite Institute
David Gollaher, President and Chief Executive Officer, CHI-California Healthcare Institute
Moderator: Michael Shuster, PhD, JD, Partner and Co-chair of the Life Sciences Group, at Fenwick & West LLP

12:45 p.m.
Meeting Wrap-Up
G. Steven Burrill, CEO, Burrill & Company

1:00 p.m.
Lunch